Literature DB >> 21334259

Development of vaccines against tuberculosis.

Anil K Tyagi1, Prachi Nangpal, Vijaya Satchidanandam.   

Abstract

Development of an effective vaccine against tuberculosis (TB) hinges on an improved understanding of the human immune responses to Mycobacterium tuberculosis. A successful vaccination strategy should be able to stimulate the appropriate arm of the immune system with concomitant generation of the memory cells. In the absence of a perfect strategy, while long term efforts of TB researchers continue to resolve the nature of protective immunity against TB and other related issues, the current approach, dictated by the urgency of a TB vaccine, employs available knowledge and technology to develop new TB vaccines and channel the promising ones to clinical trials. While Indian scientists have contributed in several areas towards the development of a TB vaccine, this review is an attempt to summarize their contributions mainly pertaining to the discovery of new antigens, immune responses elicited by antigens against TB and development of new vaccines and their evaluation in animal models.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334259     DOI: 10.1016/j.tube.2011.01.003

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  6 in total

Review 1.  Evaluating the Performance of PPE44, HSPX, ESAT-6 and CFP-10 Factors in Tuberculosis Subunit Vaccines.

Authors:  Azar Valizadeh; Abbas Ali Imani Fooladi; Hamid Sedighian; Mahdieh Mahboobi; Elaheh Gholami Parizad; Elham Behzadi; Afra Khosravi
Journal:  Curr Microbiol       Date:  2022-07-19       Impact factor: 2.343

2.  Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.

Authors:  Ming Zhang; Chunsheng Dong; Sidong Xiong
Journal:  Hum Vaccin Immunother       Date:  2016-12-14       Impact factor: 3.452

3.  Boosting BCG-primed mice with chimeric DNA vaccine HG856A induces potent multifunctional T cell responses and enhanced protection against Mycobacterium tuberculosis.

Authors:  Ping Ji; Zhi-Dong Hu; Han Kang; Qin Yuan; Hui Ma; Han-Li Wen; Juan Wu; Zhong-Ming Li; Douglas B Lowrie; Xiao-Yong Fan
Journal:  Immunol Res       Date:  2016-02       Impact factor: 4.505

4.  Evaluation of Triple Fragment Vaccine HSPX (Rv2031c) + PPE44 (Rv2770c) + Mouse IgG1 (Fcγ2a) with Auxiliary Adjuncts IL-22 in Comparison with BCG Vaccine.

Authors:  Azar Valizadeh; Afra Khosravi; Hamid Sedighian; Elham Behzadi; Elaheh Gholami Parizad; Abbas Ali Imani Fooladi
Journal:  Iran J Pathol       Date:  2022-08-13

5.  Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro.

Authors:  Priya Saikumar Lakshmi; Dheeraj Verma; Xiangdong Yang; Bethany Lloyd; Henry Daniell
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

6.  Designing and Construction Pcdna3.1 Vector Encoding Cfp10 Gene of Mycobacterium tuberculosis.

Authors:  Akram Baghani; Masoud Youssefi; Hadi Safdari; Roghayeh Teimourpour; Zahra Meshkat
Journal:  Jundishapur J Microbiol       Date:  2015-10-26       Impact factor: 0.747

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.